David Sadler:提高洁净室保温材料成本效率及风险管理

作者:本网编辑 文章来源:PHT《制药业》 发布时间:2017-06-12
David Sadler,昆山晶莱融科高分子应用材料有限公司总裁及首席执行官...

David Sadler,昆山晶莱融科高分子应用材料有限公司总裁及首席执行官

Professional Mechanical Engineer with 35 years extensive practical experiencein Hydraulics and Electronics in the Valve & Tube Industries. Having spent the last 7 years developing, marketing and installing a high performance tubular insulation system, manufactured from a high grade polymer - Kynar®Gaining significant practical experience on major Biotech and Pharma projects in Europe, India & Asia with, amongst others: Eli Lilly (Kinsale Ireland) Pfizer (Grange Castle, Ireland) Lonza AG (Visp, Switzerland) GSK Bio (Rixensart/Wavre, Belgium)Gulf Pharmaceutical (Julphar 11, UAE) Dr Reddys (Hyderabad, India) Samsung Bio (Seoul, Korea) Biocon (Bangalore, India) Indian Immunological Ltd (Vaccines) Schering Plough (Milton Keynes, UK) CSL Behring (Melbourne, Australia)

是一位在阀门及管件方面具有35年实战经验的资深工程师,随后花了7年时间发展开拓及安装由Kynar®品牌的高级聚合物制作而成的高性能管状保温材料,从中积累了很多关于生物技术及制药方面的实践经验,其中包括欧洲,印度及亚洲等地区的Eli Lilly (爱尔兰) Pfizer (爱尔兰) Lonza AG (瑞士) GSK Bio (比利时) Gulf Pharmaceutical (阿联酋) Dr Reddys (印度) Samsung Bio (韩国) Biocon (印度) Indian Immunological Ltd (印度) Schering Plough (英国) CSL Behring (澳大利亚)等等制药企业。

0
-1
收藏
评论